Higher Preoperative Serum Neuropeptide Y Concentration May Be Associated with a Better Prognosis After Surgery for Colorectal Cancer
Authors:
Open Access
Abstract
Background: The early identification of patients at risk of peri-procedural complications and poor prognosis is particularly important. We conducted our study to determine whether serum orexigenic neuropeptide Y (NPY) concentration is associated with nutritional status and prognosis among patients undergoing surgery for colorectal cancer (CRC). Materials and Methods: A cohort study with a 3-month follow-up was conducted with 84 consecutive inpatients who underwent elective surgery in one center between 2016 and 2019 for primary CRC. The clinical characteristics and nutritional status of all patients were assessed. In long-term follow-ups (median; IQR: 1322; 930–1788 days; average 3.6 years), the patients’ survival status was also checked during a telephone consultation. Results: Before CRC surgery, patients with serum NPY concentrations equal to or higher than the median value (661.70 pg/mL) had higher scores in their Mini Nutritional Assessment, Barthel, and Instrumental Activities of Daily Living (IADL) questionnaires, greater handgrip strength, a lower score in the Patient-Generated Subjective Global Assessment, and almost a three-times lower risk of perioperative complications, as well as higher Barthel and IADL scores and larger calf circumference at the 3-month follow-up visit in comparison to individuals with lower serum NPY concentrations. A higher serum NPY concentration was predictive of a low Nutritional Risk Screening 2002 score at the 3-month visit, and this was also found to have significantly influenced the patients’ survival during the 1200 days after CRC surgery. Conclusions: A higher preoperative serum NPY concentration may be related to lower nutritional risk, more favorable patient nutritional and functional status, and better survival, but further studies are required.Keywords
All Related Versions
Funding Information
- Nicolaus Copernicus University
This publication has 39 references indexed in Scilit:
- CT ‐determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancerCancer Medicine, 2024
- Impact of malnutrition on cancer recurrence, colorectal cancer‐specific death, and non‐colorectal cancer‐related death in patients with colorectal cancer who underwent curative surgeryJournal of Surgical Oncology, 2023
- A study on the effect of nutrition education based on the goal attainment theory on oral nutritional supplementation after colorectal cancer surgerySupportive Care in Cancer, 2023
- Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spreadJournal of Cancer Research and Clinical Oncology, 2022
- ESPEN practical guideline: Clinical Nutrition in cancerClinical Nutrition, 2021
- Malnutrition and cancer, diagnosis and treatmentmemo - Magazine of European Medical Oncology, 2021
- Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistanceThe Prostate, 2020
- Different effects of high-protein/low-carbohydrate versus standard hypocaloric diet on insulin resistance and lipid profile: Role of rs16147 variant of neuropeptide YDiabetes Research and Clinical Practice, 2019
- Scores of nutritional risk and parameters of nutritional status assessment as predictors of in-hospital mortality and readmissions in the general hospital populationClinical Nutrition, 2016
- Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimensCancer Medicine, 2016